Association between multiple sclerosis risk-associated SNPs and relapse and disability

Abstract

Background:

The modulating effects of the multiple sclerosis (MS) risk-associated single-nucleotide polymorphisms (SNPs) on MS clinical course are not well established.

Objectives:

The objective of this paper is to investigate whether known MS risk-associated SNPs were associated with clinical course, and whether these SNPs modified the 25(OH)D-relapse association.

Methods:

Using a prospective cohort of 141 participants with relapsing–remitting MS and genotype data followed between 2002 and 2005, genotype-vitamin D interactions and the genetic predictors of relapse were assessed using survival analysis, and genetic predictors of 25(OH)D and disability progression were evaluated by multilevel mixed-effects linear regression.

Results:

While no SNP reached statistical significance after multiple testing, five SNPs were associated with relapse, with significant cumulative genotype risk effects and two demonstrated significant allele dose-response. Two SNPs altered the 25(OH)D-relapse association with significant allele dose-response. Five SNPs modified levels of 25(OH)D, with significant cumulative genotype ‘risk’ effect, and three demonstrated significant allele dose-response. We found no consistent evidence for an association between any SNPs and disability.

Conclusions:

Our study provides evidence for an association between known MS risk-associated SNPs and relapse. Our findings indicate gene-environment interactions may be an important mechanism on MS clinical course, and provide support for the role of vitamin D in MS relapse.

Keywords

Genetic genotype-vitamin D interaction relapse disability multiple sclerosis prospective cohort

Get full access to this article

View all access options for this article.

References

Baranzini

Wang

Gibson

. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet 2009; 18: 767–778.

Martinelli-Boneschi

Esposito

Brambilla

. A genome-wide association study in progressive multiple sclerosis. Mult Scler 2012; 18: 1384–1394.

Sawcer

Hellenthal

Pirinen

. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011; 476: 214–219.

McDonnell

Mawhinney

Graham

. A study of the HLA-DR region in clinical subgroups of multiple sclerosis and its influence on prognosis. J Neurol Sci 1999; 165: 77–83.

Barcellos

Sawcer

Ramsay

. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet 2006; 15: 2813–2824.

Okuda

Srinivasan

Oksenberg

. Genotype-phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain 2009; 132: 250–259.

Cree

Reich

Khan

. Modification of multiple sclerosis phenotypes by African ancestry at HLA. Arch Neurol 2009; 66: 226–233.

van der Walt

Stankovich

Bahlo

. Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy. Neurology 2009; 73: 1018–1025.

Jensen

Stankovich

van der Walt

. Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients. PLoS One 2010; 5: e10003.

10.

Tremlett

van der Mei

Pittas

. Monthly ambient sunlight, infections and relapse rates in multiple sclerosis. Neuroepidemiology 2008; 31: 271–279.

11.

Simpson

Jr Taylor

Blizzard

. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol 2010; 68: 193–203.

12.

Mowry

Krupp

Milazzo

. Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann Neurol 2010; 67: 618–624.

13.

Runia

Hop

de Rijke

. Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis. Neurology 2012; 79: 261–266.

14.

Simon

Munger

Xing

. Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis. Mult Scler 2010; 16: 133–138.

15.

Dickinson

Perera

van der Mei

. Past environmental sun exposure and risk of multiple sclerosis: A role for the Cdx-2 vitamin D receptor variant in this interaction. Mult Scler 2009; 15: 563–570.

16.

Ramagopalan

Heger

Berlanga

. A ChIP-seq defined genome-wide map of vitamin D receptor binding: Associations with disease and evolution. Genome Res 2010; 20: 1352–1360.

17.

Ascherio

Munger

Simon

. Vitamin D and multiple sclerosis. Lancet Neurol 2010; 9: 599–612.

18.

Disanto

Sandve

Berlanga-Taylor

. Vitamin D receptor binding, chromatin states and association with multiple sclerosis. Hum Mol Genet 2012; 21: 3575–3586.

19.

Pittas

Ponsonby

van der Mei

. Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis. J Neurol 2009; 256: 577–585.

20.

McDonald

Compston

Edan

. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121–127.

21.

Simpson

Jr Taylor

Dwyer

. Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis. Mult Scler 2012; 18: 799–806.

22.

The Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene). Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 2009; 41: 824–828.

23.

Patsopoulos

de Bakker

Esposito

. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol 2011; 70: 897–912.

24.

Browning

. A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals. Am J Hum Genet 2009; 84: 210–223.

25.

Clarke

Zheng-Bradley

Smith

. The 1000 Genomes Project: Data management and community access. Nat Methods 2012; 9: 459–462.

26.

Purcell

Neale

Todd-Brown

. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559–575.

27.

van der Mei

Ponsonby

Dwyer

. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: Case-control study. BMJ 2003; 327: 316.

28.

Prentice

Williams

Peterson

. On the regression analysis of multivariate failure time data. Biometrika 1981; 68: 373–379.

29.

Noseworthy

Lucchinetti

Rodriguez

. Multiple sclerosis. N Engl J Med. 2000; 343: 938–952.

30.

Sosa

Forsthuber

. The critical role of antigen-presentation-induced cytokine crosstalk in the central nervous system in multiple sclerosis and experimental autoimmune encephalomyelitis. J Interferon Cytokine Res 2011; 31: 753–768.

31.

Lin

Charlesworth

van der Mei

. The genetics of multiple sclerosis. Pract Neurol 2012; 12: 279–288.

32.

Ramagopalan

Maugeri

Handunnetthi

. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet 2009; 5: e1000369.

33.

Zierold

Darwish

DeLuca

. Two vitamin D response elements function in the rat 1,25-dihydroxyvitamin D 24-hydroxylase promoter. J Biol Chem 1995; 270: 1675–1678.

34.

Ohyama

Ozono

Uchida

. Functional assessment of two vitamin D-responsive elements in the rat 25-hydroxyvitamin D3 24-hydroxylase gene. J Biol Chem 1996; 271: 30381–30385.

Association between multiple sclerosis risk-associated SNPs and relapse and disability – a prospective cohort study

Abstract

Background:

Objectives:

Methods:

Results:

Conclusions:

Keywords

Get full access to this article

References